Kidney-Hypertension drug trial halted midway
Disease control
Terminated
This study tested an experimental drug called KBP-5074 for people with moderate to severe chronic kidney disease whose high blood pressure was not controlled by at least two other medications. The goal was to see if the drug could safely lower blood pressure over 12 weeks and mai…
Phase: PHASE3 • Sponsor: KBP Biosciences • Aim: Disease control
Last updated May 15, 2026 11:53 UTC